Canada Stocks to Watch: Bauer, Valeant, Questerre and more

Bauer Performance Sports Ltd. said it plans to sell $110 million of shares in the U.S. and Canada and has applied for a New York Stock Exchange listing.

Allergan Inc. said its board has rejected the latest takeover bid from Valeant Pharmaceuticals International Inc. and Pershing Square Capital Management L.P., saying the deal creates significant risks and uncertainties and isn’t in the best interests of the company or its stockholders.